Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas

NCT04407741 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
Lymphoma

Interventions

DRUG: SHR2554+SHR1701
DRUG: SHR1701

Sponsor

Chinese PLA General Hospital